InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Discover the full record of transactions filed by Freund John Gordon, Director. Insider active across 3 companies, notably COLLEGIUM PHARMACEUTICAL, INC. Cumulatively, 12 disclosures have been published. Total volume traded: €5m. The latest transaction was disclosed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
08,324 shares0
Common Stock
SEC:0001562180-22-005236:0·
014,035 shares0
Common Stock
SEC:0001062993-22-013302:0·
€464,21917,990 shares@ €25.80430.074% mcap18.7% of flow
Common Stock
SEC:0001562180-21-004319·
€464,21917,990 shares@ €25.80430.074% mcap9.3% of flow
Common Stock
SEC:0001562180-21-004319:0·
03,848 shares0
Common Stock
SEC:0001562180-21-004257·
03,848 shares0
Common Stock
SEC:0001562180-21-004257:0·
€668,83526,367 shares@ €25.36640.11% mcap26.9% of flow
Common Stock
SEC:0001562180-21-003880·
€668,83526,367 shares@ €25.36640.11% mcap13.4% of flow
Common Stock
SEC:0001562180-21-003880:0·
€1m50,827 shares@ €26.64090.22% mcap54.4% of flow
Common Stock
SEC:0001562180-21-003755·
€1m50,827 shares@ €26.64090.22% mcap27.2% of flow
Common Stock
SEC:0001562180-21-003755:0·
09,941 shares0
Common Stock
SEC:0001192482-21-000460·
09,941 shares0
Common Stock
SEC:0001192482-21-000460:0·
12 of 12 declarations
About Freund John Gordon
John Gordon Freund is a Director at Collegium Pharmaceutical, Inc. and SI-BONE, Inc. As a board member, he participates in governance and strategic decision-making. His experience in the pharmaceutical sector is valuable for these companies.
